Back to Press Releases

INSIGHTEC RECEIVES FDA APPROVAL FOR EXABLATE NEURO FOR 1.5T MRI IN THE TREATMENT OF ESSENTIAL TREMOR

May 9, 2017
GetBig6.jpg

HAIFA, ISRAEL May 9, 2017 – INSIGHTEC, the leader in MR-guided Focused Ultrasound (MRgFUS), announced today that the FDA has approved its Exablate Neuro (Model 4000) system for use with 1.5T MRI in the non-invasive treatment of essential tremor (ET) in patients who have not responded to medication.

 

Exablate Neuro uses focused ultrasound waves to target and ablate the Vim nucleus of the thalamus with no surgical incisions or implants. The treatment is done under MRI guidance for real-time treatment monitoring. In July 2016, INSIGHTEC received FDA approval for the Exablate Neurofor use with 3.0T MRI systems. This approval for a new MR head coil significantly opens new potential markets for INSIGHTEC’S Exablate Neuro as 1.5T systems are the most common MRI systems in use today.

 

Essential tremor is the most common movement disorder, affecting more than 42 million people worldwide. For patients suffering from essential tremor, performing everyday tasks presents a challenge and impacts their quality of life.

 

 “Being able to bring MR-guided focused ultrasound to hospitals that have 1.5T MRIs will enable more essential tremor patients to have access to this non-invasive treatment option using INSIGHTEC’s ground-breaking technology.” stated Maurice R. Ferré MD, INSIGHTEC Chief Executive Officer and Chairman of the Board.

 

To read more about the Exablate Neuro, please visit: http://www.insightec.com/us/clinical/neurosurgery

 

About INSIGHTEC

INSIGHTEC is the world leader and innovator of MR-guided Focused Ultrasound (MRgFUS). The company’s non-invasive therapy platforms, Exablate and Exablate Neuro, are proven technology based on sound clinical evidence for treating essential tremor, painful bone metastases and uterine fibroids. The company is dedicated to improving patient lives by collaborating with physicians, medical institutions, academic researchers and regulatory bodies around the world. For more information, please visit: www.insightec.com. Patient information is available at www.essential-tremor.com

Please fill in the following details and we will get in touch with you. (* Required)

agreement Error

Thank You!

Thank you for contacting us! We will get back to you shortly.

Thank You!

This site is brought to you by INSIGHTEC, © 2018 INSIGHTEC Ltd. All rights reserved.

NGSoft logo